S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund
S&P 500   4,567.18
DOW   36,124.56
QQQ   387.29
Investing in quantum computing: A guide 
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What is dividend harvesting?
Marvell Technology at a critical pivot: 30% upside is possible
Countries Are Investing Heavily Into Securing Energy Independence (Ad)
What analysts wanted out of Chewy stock is finally here
Even Scrooge can’t pass up these 3 bargain stocks
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology (Ad)
The truth about DocuSign's relevancy in today's world: Surprise
SoFi expands ETF business with options-driven income fund

Fisher & Paykel Healthcare Stock Price, News & Analysis (OTCMKTS:FSPKF)

$14.11
0.00 (0.00%)
(As of 12/5/2023 ET)
Compare
Today's Range
$14.11
$14.11
50-Day Range
$12.00
$14.11
52-Week Range
$12.00
$16.69
Volume
N/A
Average Volume
700 shs
Market Capitalization
N/A
P/E Ratio
83.18
Dividend Yield
0.46%
Price Target
N/A

FSPKF stock logo

About Fisher & Paykel Healthcare Stock (OTCMKTS:FSPKF)

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems worldwide. It also provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products, including humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, humidifiers, and accessories. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

FSPKF Stock Price History

FSPKF Stock News Headlines

Fisher & Paykel ups pre-Christmas dividend
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
See More Headlines
Receive FSPKF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fisher & Paykel Healthcare and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:FSPKF
CIK
N/A
Fax
N/A
Employees
6,391
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Lewis G. Gradon (Age 62)
    MD, CEO & Executive Director
    Comp: $1.51M
  • Ms. Lyndal York
    Chief Financial Officer
  • Dr. Andrew Somervell
    Vice President of Products & Technology
  • Hayden Brown
    Head of Capital Markets & Investor Relations
  • Raelene Leonard
    Company Secretary & General Counsel
  • Daniel Adolph
    Senior Communications & Investor Relations Manager
  • Mr. Paul N. Shearer B.Com.
    Senior Vice President of Sales & Marketing
  • Ms. Nicola Talbot
    Vice President of Human Resources
  • Mr. Jonathan Rhodes
    Vice President of Supply Chain, Facilities & Sustainability
  • Mr. Marcus Driller
    Vice President of Corporate














FSPKF Stock Analysis - Frequently Asked Questions

Should I buy or sell Fisher & Paykel Healthcare stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Fisher & Paykel Healthcare in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" FSPKF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FSPKF, but not buy additional shares or sell existing shares.
View FSPKF analyst ratings
or view top-rated stocks.

How have FSPKF shares performed in 2023?

Fisher & Paykel Healthcare's stock was trading at $13.63 at the beginning of 2023. Since then, FSPKF stock has increased by 3.5% and is now trading at $14.11.
View the best growth stocks for 2023 here
.

Are investors shorting Fisher & Paykel Healthcare?

Fisher & Paykel Healthcare saw a increase in short interest during the month of November. As of November 15th, there was short interest totaling 1,307,900 shares, an increase of 15.6% from the October 31st total of 1,131,300 shares. Based on an average daily trading volume, of 2,000 shares, the short-interest ratio is currently 654.0 days.
View Fisher & Paykel Healthcare's Short Interest
.

Is Fisher & Paykel Healthcare a good dividend stock?

Fisher & Paykel Healthcare (OTCMKTS:FSPKF) pays an annual dividend of $0.07 per share and currently has a dividend yield of 2.29%. The dividend payout ratio is 38.45%. This payout ratio is at a healthy, sustainable level, below 75%.

How do I buy shares of Fisher & Paykel Healthcare?

Shares of FSPKF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:FSPKF) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -